387 related articles for article (PubMed ID: 27565564)
1. Establishment of a simple cell-based ELISA for the direct detection of abnormal isoform of prion protein from prion-infected cells without cell lysis and proteinase K treatment.
Shan Z; Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
Prion; 2016 Jul; 10(4):305-18. PubMed ID: 27565564
[TBL] [Abstract][Full Text] [Related]
2. Prion infectivity is encoded exclusively within the structure of proteinase K-resistant fragments of synthetically generated recombinant PrP
Wang F; Wang X; Abskharon R; Ma J
Acta Neuropathol Commun; 2018 Apr; 6(1):30. PubMed ID: 29699569
[TBL] [Abstract][Full Text] [Related]
3. An aggregation-specific enzyme-linked immunosorbent assay: detection of conformational differences between recombinant PrP protein dimers and PrP(Sc) aggregates.
Pan T; Chang B; Wong P; Li C; Li R; Kang SC; Robinson JD; Thompsett AR; Tein P; Yin S; Barnard G; McConnell I; Brown DR; Wisniewski T; Sy MS
J Virol; 2005 Oct; 79(19):12355-64. PubMed ID: 16160162
[TBL] [Abstract][Full Text] [Related]
4. Guanidine hydrochloride extraction and detection of prion proteins in mouse and hamster prion diseases by ELISA.
Kang SC; Li R; Wang C; Pan T; Liu T; Rubenstein R; Barnard G; Wong BS; Sy MS
J Pathol; 2003 Apr; 199(4):534-41. PubMed ID: 12635145
[TBL] [Abstract][Full Text] [Related]
5. A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds.
Ladner-Keay CL; Ross L; Perez-Pineiro R; Zhang L; Bjorndahl TC; Cashman N; Wishart DS
Prion; 2018; 12(5-6):280-300. PubMed ID: 30223704
[TBL] [Abstract][Full Text] [Related]
6. Proteinase K and the structure of PrPSc: The good, the bad and the ugly.
Silva CJ; Vázquez-Fernández E; Onisko B; Requena JR
Virus Res; 2015 Sep; 207():120-6. PubMed ID: 25816779
[TBL] [Abstract][Full Text] [Related]
7. Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrP
Pankiewicz JE; Sanchez S; Kirshenbaum K; Kascsak RB; Kascsak RJ; Sadowski MJ
Mol Neurobiol; 2019 Mar; 56(3):2073-2091. PubMed ID: 29987703
[TBL] [Abstract][Full Text] [Related]
8. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion.
Pan T; Li R; Kang SC; Wong BS; Wisniewski T; Sy MS
J Neurochem; 2004 Sep; 90(5):1205-17. PubMed ID: 15312175
[TBL] [Abstract][Full Text] [Related]
9. Flow Cytometric Detection of PrP
Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046463
[TBL] [Abstract][Full Text] [Related]
10. Intermolecular crosslinking of abnormal prion protein is efficiently induced by a primuline-sensitized photoreaction.
Teruya K; Nishizawa K; Oguma A; Sakasegawa Y; Kitamoto T; Doh-Ura K
Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):384-394. PubMed ID: 30447252
[TBL] [Abstract][Full Text] [Related]
11. A highly sensitive immunoassay for the detection of prion-infected material in whole human blood without the use of proteinase K.
Tattum MH; Jones S; Pal S; Khalili-Shirazi A; Collinge J; Jackson GS
Transfusion; 2010 Dec; 50(12):2619-27. PubMed ID: 20561299
[TBL] [Abstract][Full Text] [Related]
12. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
[TBL] [Abstract][Full Text] [Related]
13. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
14. Influence of guanidine on proteinase K resistance in vitro and infectivity of scrapie prion protein PrP(Sc).
Gao JM; Zhou XB; Xiao XL; Zhang J; Chen L; Gao C; Zhang BY; Dong XP
Acta Virol; 2006; 50(1):25-32. PubMed ID: 16599182
[TBL] [Abstract][Full Text] [Related]
15. A Fluorescent Oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases.
Imberdis T; Ayrolles-Torro A; Duarte Rodrigues A; Torrent J; Alvarez-Martinez MT; Kovacs GG; Verdier JM; Robitzer M; Perrier V
Mol Neurodegener; 2016 Jan; 11():11. PubMed ID: 26809712
[TBL] [Abstract][Full Text] [Related]
16. Detection, quantification, and glycotyping of prion protein in specifically activated enzyme-linked immunosorbent assay plates.
Triantaphyllidou IE; Sklaviadis T; Vynios DH
Anal Biochem; 2006 Dec; 359(2):176-82. PubMed ID: 17092479
[TBL] [Abstract][Full Text] [Related]
17. Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.
Akasaka K; Maeno A; Murayama T; Tachibana H; Fujita Y; Yamanaka H; Nishida N; Atarashi R
Prion; 2014; 8(4):314-8. PubMed ID: 25482603
[TBL] [Abstract][Full Text] [Related]
18. Chicken antibody against a restrictive epitope of prion protein distinguishes normal and abnormal prion proteins.
Miyamoto K; Kimura S; Nakamura N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
Biologicals; 2007 Oct; 35(4):303-8. PubMed ID: 17363268
[TBL] [Abstract][Full Text] [Related]
19. Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions.
Saverioni D; Notari S; Capellari S; Poggiolini I; Giese A; Kretzschmar HA; Parchi P
J Biol Chem; 2013 Sep; 288(39):27972-85. PubMed ID: 23897825
[TBL] [Abstract][Full Text] [Related]
20. The N-terminal sequence of prion protein consists an epitope specific to the abnormal isoform of prion protein (PrP(Sc)).
Masujin K; Kaku-Ushiki Y; Miwa R; Okada H; Shimizu Y; Kasai K; Matsuura Y; Yokoyama T
PLoS One; 2013; 8(2):e58013. PubMed ID: 23469131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]